Healthcare, Pharma & Life Sciences

Dusseldorf – November 03, 2026 -- More than 500 start-ups will exhibit among several thousand exhibitors at MEDICA 2026, held 16-19 November in Düsseldorf, and the 15th MEDICA START-UP COMPETITION will stage its pitch final on the new MEDICA MAIN STAGE in Hall 12 for the first time.

START-UP PARK in Hall 17 hosts more than 100 international companies

The MEDICA START-UP PARK sits inside the new Digital Health Hub, next to the new MEDICA DIGITAL HEALTH STAGE curated by Prof. Dr. David Matusiewicz. Exhibitors cover AI, digital health, medical technology, robotics and diagnostics.

Deerfield, Illinois – November 03, 2026 -- Vantive has signed a definitive agreement to divest the majority of its hemodialysis (HD) assets and related operations to Rockwell Medical (Nasdaq: RMTI), with closing expected in mid-2027.

Rockwell Medical acquires concentrates, monitors and water treatment systems

Rockwell will take over Vantive's hemodialysis concentrates, HD monitors and water treatment systems, together with related consumables and technical services. Ownership of Vantive's manufacturing facility in Medolla, Italy will also transfer to Rockwell on completion, to support capacity and the continued development of the global HD business.

Vantive's dialyzer portfolio is excluded from the deal. That includes the Theranova dialyzer, which enables HDx (expanded hemodialysis) therapy.

Berlin – November 03, 2026 -- Germany's statutory health physicians' association KBV is calling for the planned Health Security Act (GeSiG) to be tabled as a draft "very soon", saying current social insurance law provides no adequate framework for outpatient care in a crisis or defense scenario.

About 200 experts from politics, the military, healthcare, rescue and aid organizations, and civil protection attended the symposium "Healthcare in Total Defense" in Berlin. The Kassenärztliche Bundesvereinigung (KBV) and Lt. Gen. (Surgeon) Dr. Ralf Hoffmann co-hosted. Hoffmann is the Defense Ministry's medical adviser and commander of the Bundeswehr Joint Medical Service. The event was the second edition of the format.

PLYMOUTH MEETING – November 03, 2026 -- INOVIO (NASDAQ: INO) will present its INO-D001 program for Hemophilia A at the World Federation of Hemophilia New Technology & Gene Therapy (NTGT) Workshop in Montreal on Thursday, Nov. 12, extending its DNA medicine work beyond HPV-related diseases, cancer and infectious diseases.

INOVIO schedules rare disease presentation in New York for Nov. 8

The company will speak at the Soft Bones Third International Scientific Meeting on Hypophosphatasia in New York on Sunday, Nov. 8. Its presentation is titled "Rare Disease Protein Replacement Therapeutics: The Transformational Potential of Next-Gen DNA Medicine."

Montreal workshop session focuses on INO-D001 for Hemophilia A

The Nov. 12 presentation at the WFH NTGT Workshop is dedicated to INO-D001 in Hemophilia A. The two appearances are four days apart, on Nov. 8 and Nov. 12.

Fort Wayne – November 03, 2026 -- James W. Edlund, MD, CWSP, Medical Director of the Parkview Center for Wound Healing, has been recognized by The Inner Circle as a 2026 Pinnacle Lifetime Member. He oversees all medical aspects of four Parkview Health wound facilities.

Edlund directs four Parkview wound-care facilities with a 12-clinician team

His team includes two physicians, a clinical nurse specialist and nine nurse practitioners. Edlund has more than four decades of experience in surgical and wound management disciplines.

Hyperbaric oxygen assessments remain part of his clinical schedule

Alongside his administrative duties, Edlund sees patients two to three days a week. He specializes in assessing candidates for hyperbaric oxygen therapy, which supports recovery for patients with chronic and complex wounds.

Vancouver – November 03, 2026 -- The International Society for Cell & Gene Therapy (ISCT) is renaming its Institute of Training & Development the ISCT Academy of Training & Development, three years after the program launched in 2023.

ISCT CEO Queenie Jang said the program has outgrown the institute label and that the new name reflects its scale and global reach.

ISCT earned ANSI accreditation for workforce training in 2024

In 2024, ISCT became the first cell and gene therapy (CGT) organization accredited by the ANSI National Accreditation Board for workforce development and training. The accreditation confirms that its programs meet internationally recognized standards. ISCT President Daniel J. Weiss called it a defining milestone reached in a relatively short period.

Addison – November 02, 2026 -- Solis Mammography and Jefferson Health are opening two joint breast health centers: Jefferson-Solis Mammography Cinnaminson, New Jersey, on Nov. 2, 2026, and Jefferson-Solis Mammography Ardmore, Pennsylvania, on Nov. 9, 2026.

Cinnaminson and Ardmore centers open one week apart in retail shopping locations

The Cinnaminson center is at the Shoppes at Cinnaminson, 175 US-130, Suite C. The Ardmore center is at Ardmore West Shopping Center, 163 West Lancaster Avenue, Suite 110, near Suburban Square. Both sites extend the retail-style footprint Solis uses, in partnership with a health system that operates 33 hospital campuses and more than 700 outpatient and urgent care locations.

Hauppauge – November 02, 2026 -- SightMD, an ophthalmic group with 38 locations across New York, has added cornea specialist Brittany M. Perzia, MD, to its Yonkers office, where she is now seeing patients.

Dr. Perzia specializes in Cornea & External Disease and Comprehensive Ophthalmology. Her clinical interests include corneal disease, ocular surface disorders, complex anterior segment conditions and cataracts. She provides both medical and surgical eye care.

Perzia trained at Yale and SUNY Stony Brook before joining SightMD

Dr. Perzia completed her ophthalmology residency at Yale University School of Medicine. She earned her medical degree from the Renaissance School of Medicine at SUNY Stony Brook and graduated as Valedictorian from Boston College. Her honors include the Yale Academic Excellence Award and induction into the Alpha Omega Alpha Honor Society and the Gold Humanism Honor Society.

BOSTON – November 01, 2026 -- More than 4,000 registered nurses at Brigham and Women's Hospital will begin an open-ended strike at 7 a.m. on November 12 after rejecting Mass General Brigham's (MGB) "last, best, and final" contract offer. The Massachusetts Nurses Association (MNA), which represents the nurses, describes the action as the largest open-ended strike in Massachusetts history.

The Brigham MNA Bargaining Committee issued the 10-day strike notice on Sunday, November 1. Members voted to reject the offer on October 23. Talks with MGB resume on November 9, three days before the strike deadline.

"We are ready to strike but are equally prepared to negotiate a fair contract," said Kelly Morgan, RN, a labor and delivery nurse and chair of the bargaining committee.

Nurses demand limits on temporary staff, a float differential and insurance choice

The union's contract priorities include:

Perth – November 01, 2026 -- Orthocell Limited (ASX: OCC) sold 92 units of its Remplir nerve repair wrap in the U.S. in October 2026, generating AU$279,000 in revenue, an 84% increase on the average monthly sales of 50 units in Q1 FY27.

It is the strongest month of U.S. sales since the product launched. The company released the figures ahead of its Annual General Meeting on 6 November 2026. Standard quarterly reporting will continue after the meeting.

Surgeon adoption and distributor reach drive the October uplift

Orthocell attributes the result to four factors: growing surgeon adoption, increasing repeat use, a larger base of actively selling distributor representatives and broader hospital access across key U.S. markets. Remplir is a collagen nerve wrap for the repair and protection of peripheral nerves. It is FDA-cleared and manufactured by Orthocell in Australia.